Insider Transactions in Q2 2021 at Abeona Therapeutics Inc. (ABEO)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 01
2021
|
Vishwas Seshadri Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
300,000
+37.5%
|
-
|
|
May 25
2021
|
Leila Alland Director |
BUY
Grant, award, or other acquisition
|
Direct |
77,181
+50.0%
|
-
|
|
May 25
2021
|
Steven H Rouhandeh Director |
BUY
Grant, award, or other acquisition
|
Direct |
38,590
+6.74%
|
-
|
|
May 25
2021
|
Mark Alvino Director |
BUY
Grant, award, or other acquisition
|
Direct |
77,181
+48.43%
|
-
|
|
May 25
2021
|
Christine Berni Silverstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
38,590
+24.55%
|
-
|
|
May 25
2021
|
Faith L. Charles Director |
BUY
Grant, award, or other acquisition
|
Direct |
77,181
+50.0%
|
-
|
|
May 25
2021
|
Todd Wider Director |
BUY
Grant, award, or other acquisition
|
Direct |
38,590
+37.77%
|
-
|
|
May 25
2021
|
Paul Elliot Mann Director |
BUY
Grant, award, or other acquisition
|
Direct |
38,590
+50.0%
|
-
|
|
May 25
2021
|
Donald A. Wuchterl Director |
BUY
Grant, award, or other acquisition
|
Direct |
77,181
+50.0%
|
-
|
|
May 03
2021
|
Sco Capital Partners LLC Director |
SELL
Open market or private sale
|
Indirect |
80,000
-0.72%
|
$160,000
$2.01 P/Share
|
|
Apr 05
2021
|
Edward Carr Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
35,000
-15.47%
|
$35,000
$1.8 P/Share
|
|
Apr 01
2021
|
Edward Carr Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
20,445
-8.29%
|
$20,445
$1.85 P/Share
|